
Mary Beckerle
American cell biologist
Mary C. Beckerle is an American cell biologist who studies cancer at the Huntsman Cancer Institute at the University of Utah School of Medicine. At Huntsman Cancer Institute, she is the CEO, and is Associate Vice President for Cancer Affairs at the University of Utah.2
From Wikipedia’s article on Mary Beckerle (this version), CC BY-SA 4.0.
About
Beckerle's research helped to define a novel molecular pathway for cell motility, and more recently, she has begun research into Ewing's sarcoma, a pediatric bone cancer. Beckerle's lab made a ground breaking discovery in regards to Ewing's Sarcoma in relation to the EWS/FLI protein. Her lab discovered EWS/FLI to disrupt the internal cellular skeleton, which decreases the ability of cells to adhere to their proper environment. This can help explain the metastasis of tumors in patients with Ewing's sarcoma.
From Wikipedia’s article on Mary Beckerle, shared under CC BY-SA 4.0.2
Companies
- ExelixisBoard member Jan 9, 2024 to now9
- Johnson & JohnsonBoard member Jun 9, 2015 to now10
- Huntsman CorporationBoard member May 9, 2011 to now11
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Exelixis EXEL16,079 shares12$1.0M at $62.59Aug 10, 2026
Huntsman Corporation HUN22,151 shares13$183.7K at $8.29Feb 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 10, 2026Sold 9,812 shares at $53.66 of Exelixis12
- May 27, 2026Granted 8,367 shares of Exelixis14
- May 7, 2026Sold 7,712 shares at $48.45 of Exelixis15
- May 7, 2026Exercised options 3,856 shares at $23.24 of Exelixis15
- Feb 12, 2026Granted 12,434 shares of Huntsman Corporation13
- Nov 11, 2025Sold 18,838 shares at $41.90 of Exelixis16
- Nov 11, 2025Sold 5,784 shares at $42.03 of Exelixis16
- Nov 11, 2025Exercised options 5,784 shares at $23.24 of Exelixis16
- May 29, 2025Granted 9,812 shares of Exelixis17
- Feb 14, 2025Sold 3,856 shares at $34.90 of Exelixis18
- Feb 14, 2025Sold 8,354 shares at $34.87 of Exelixis18
- Feb 14, 2025Exercised options 8,354 shares at $23.24 of Exelixis18
- Feb 13, 2025Granted 9,717 shares of Huntsman Corporation19
- Nov 6, 2024Sold 20,201 shares at $21.42 of Huntsman Corporation20
- May 31, 2024Granted 18,838 shares of Exelixis21
- Feb 15, 2024Granted 6,895 shares of Huntsman Corporation22
- Jan 5, 2024Granted 15,424 shares of Exelixis23
- Feb 16, 2023Granted 4,700 shares of Huntsman Corporation24
- Feb 17, 2022Granted 3,533 shares of Huntsman Corporation25
Early life and education
Mary Catherine Beckerle was born in Rivers Edge, New Jersey to Martin and Mickey Beckerle. She is the oldest of three daughters. Her father worked at the New York Telephone Co. and died at the age of 36 of emphysema. Her mother was a registered nurse. After high school, Beckerle attended Wells College in New York, where she earned a B. A. in Biology and Psychology. She graduated magna cum laude and was a member of Phi Beta Kappa. Before continuing her education, she took a year off and worked in a cellular biology research laboratory at University of Texas Southwest Medical Center. After this, she attended the University of Colorado Boulder where she earned a PhD. in Molecular Biology. Her education then continued at the University of North Carolina Chapel Hill where she was a postdoctoral fellow in Anatomy and Cell Biology.
From Wikipedia’s article on Mary Beckerle (this version), CC BY-SA 4.0.
Career
Occupation: biologist.7
- Since 2015Board member, Johnson & Johnson6
- Date not recordedWorked at University of Utah4 5
Beckerle joined the University of Utah faculty as an assistant professor of biology. She continued at the University of Utah and was one of the first professors to move into the Huntsman Cancer Institute when it opened in 1999. Also in 1999, she was awarded the Ralph E. and Willa T. Main Presidential Endowed Chair in Cancer Research at the University of Utah. She led a program specializing in cancer cell biology until 2003. In 2003, she was named the deputy director of the center. In 2006, she was named the CEO and the director of Huntsman Cancer Institute. In 2009, she was also named the Associate Vice President for Cancer Affairs at the University of Utah. She holds the Jon M. Huntsman Presidential Endowed Chair at the University of Utah, where she has also been promoted to a distinguished professorship in the biology department.
In 1990, Beckerle was on the editorial board of Molecular Biology of the cell. She was awarded a Guggenheim Fellowship in Molecular and Cellular Biology at the Curie Institute in Paris in 1999. In 2006, Beckerle was the president of the American Society of Cell Biology. She was elected to the American Academy of Arts and Sciences in 2008. In 2013, she was elected to the Board of Directors of the American Association for Cancer Research. Beckerle was elected to the American Philosophical Society in the April 2017 group of inductees that also included Barack Obama. She was on the Life Sciences jury for the Infosys Prize in 2020.
She is a member of the U. S. National Academy of Sciences.
Read more
2017 Huntsman Cancer Institute firing and reinstatement
On 17 April 2017, Beckerle was terminated as CEO and Director of the Huntsman Cancer Institute via an email from University of Utah President David W. Pershing and Senior Vice President for Health Sciences Vivian Lee. The university did not disclose reasons for the dismissal, but members of the Huntsman family issued several public criticisms of the move, and called for Beckerle's reinstatement while criticizing the leadership shown by Pershing and Lee. In subsequent days, members of the family made media appearances, published full page newspaper ads reiterating their support for cancer research and Beckerle, and even called for the termination of top university officials. Beckerle's firing occurred as the University of Utah and Huntsman Cancer Foundation were negotiating terms for a new memorandum of understanding to govern the operations of Huntsman Cancer Institute. Some Huntsman Cancer Institute faculty and staff were among over 3600 individuals who signed a petition requesting Beckerle be restored to her position. On 19 April, roughly 100 demonstrators marched from the Huntsman Cancer Institute facilities across the university campus to the Office of President Pershing, calling for Beckerle's return. This came on the heels of other meetings and protests in the university community. On the morning of 25 April, the university's board of trustees met in a closed session, after which Pershing briefly spoke to reporters, mentioning that an announcement would be forthcoming later in the day. Within a few hours, it was announced that Beckerle would be reinstated as CEO and Director of the Huntsman Cancer Institute, and would report directly to the University President, bypassing Vivian Lee. On 28 April, Vivian Lee announced via email that, effective the same day, she was stepping down as the university's senior vice president for health sciences, dean of the medical school, and CEO of the healthcare system.
From Wikipedia’s article on Mary Beckerle (this version), CC BY-SA 4.0.
Personal life
While at the University of North Carolina Chapel Hill, Beckerle met David Murrell. She would go on to marry him. The couple shares one son.
From Wikipedia’s article on Mary Beckerle (this version), CC BY-SA 4.0.
Awards
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataMary Beckerle on Wikidata
- 2WikipediaMary Beckerle on Wikipedia
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARExelixis, Board member
- 10Wikidata and SEC EDGARJohnson & Johnson, Board member
- 11SEC EDGARHuntsman Corporation, Board member
- 12
- 13
- 14SEC EDGARForm 4 filed May 29, 2026
- 15SEC EDGARForm 4 filed May 8, 2026
- 16SEC EDGARForm 4 filed Nov 13, 2025
- 17SEC EDGARForm 4 filed May 30, 2025
- 18SEC EDGARForm 4 filed Feb 19, 2025
- 19SEC EDGARForm 4 filed Feb 18, 2025
- 20SEC EDGARForm 4 filed Nov 8, 2024
- 21SEC EDGARForm 4 filed Jun 4, 2024
- 22SEC EDGARForm 4 filed Feb 20, 2024
- 23SEC EDGARForm 4 filed Jan 9, 2024
- 24SEC EDGARForm 4 filed Feb 21, 2023
- 25SEC EDGARForm 4 filed Feb 22, 2022
- 26Wikimedia CommonsMary Beckerle photo by HCIPublicAffairs, CC BY-SA 4.0